Melatonin protects ADSCs from ROS and enhances their therapeutic potency in a rat model of myocardial infarction

Myocardial infarction (MI) is a major cause of death and disability worldwide. In the last decade, mesenchymal stem cells (MSCs) based cell therapy has emerged as a promising therapeutic strategy. Although great advance have been made using MSCs to treat MI, the low viability of transplanted MSCs se...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Ping, Liu, Jianfeng, Shi, Jinxin, Zhou, Qian, Liu, Jie, Zhang, Xianwei, Du, Zhiyan, Liu, Qiaowei, Guo, Yuanyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4568927/
https://www.ncbi.nlm.nih.gov/pubmed/26081690
http://dx.doi.org/10.1111/jcmm.12610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4568927/
https://www.ncbi.nlm.nih.gov/pubmed/26081690
http://dx.doi.org/10.1111/jcmm.12610

Ejemplares similares